Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New thrombolytic strategies

F Van de Werf1

  • 1Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium.

Australian and New Zealand Journal of Medicine
|December 1, 1993
PubMed
Summary

Current thrombolytic therapies show low rates of effective coronary reperfusion. New approaches, including improved thrombolytic agents and antiplatelet therapies, are being developed to enhance treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Dabigatran versus warfarin in patients with mechanical heart valves: reply.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology.

Acute cardiac care·2011
Same author

Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve.

Quality & safety in health care·2010
Same author

[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology].

Revue medicale de Bruxelles·2010
Same author

[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology].

Revue medicale de Liege·2010

Area of Science:

  • Cardiology
  • Pharmacology
  • Biotechnology

Background:

  • Effective coronary reperfusion rates with current thrombolytic agents remain suboptimal.
  • Thrombolytic therapy is crucial for treating acute coronary events.

Purpose of the Study:

  • To review current limitations in thrombolytic therapy.
  • To explore novel strategies for enhancing thrombolytic efficacy in coronary reperfusion.

Main Methods:

  • Review of recent angiographic studies.
  • Analysis of emerging thrombolytic agents and adjunctive therapies.

Main Results:

  • Current thrombolytic regimens achieve low rates of TIMI grade 3 flow.
  • Newer approaches involve modified thrombolytic agents, antibody conjugates, and advanced antithrombotic drugs.

Conclusions:

  • Development of improved thrombolytic agents and adjunctive therapies holds promise for better coronary reperfusion.
  • Ongoing clinical trials are evaluating these novel approaches for improved patient outcomes.

Related Experiment Videos